☆ 4.7 Article

Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson's Disease

NUTRIENTS (2022)

Related references

Note: Only part of the references are listed.

Article Agriculture, Multidisciplinary

Lactobacillus plantarum DP189 Reduces α-SYN Aggravation in MPTP-Induced Parkinson's Disease Mice via Regulating Oxidative Damage, Inflammation, and Gut Microbiota Disorder

Lei Wang et al.

Summary: Lactobacillus plantarum DP189 alleviates alpha-synuclein (α-SYN) aggregates in the substantia nigra (SN) of Parkinson's disease (PD) mice through various mechanisms, including activating antioxidant and anti-inflammatory pathways, suppressing the expression of inflammasomes, and modulating gut microbiota. These findings suggest that L. plantarum DP189 has the potential therapeutic effect in mitigating neurodegeneration in PD.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Anti-depressive-like behaviors of APN KO mice involve Trkb/BDNF signaling related neuroinflammatory changes

Weifen Li et al.

Summary: Research suggests that adiponectin deprivation may enhance antidepressive-like behaviors in a depression model, and changes in adiponectin receptors and IBA-1 in antidepressive responses may be associated with dysregulated neuroinflammatory status and BDNF signaling.

MOLECULAR PSYCHIATRY (2022)

Add to Collection

Article Food Science & Technology

Polymannuronic acid prebiotic plus Lacticaseibacillus rhamnosus GG probiotic as a novel synbiotic promoted their separate neuroprotection Parkinson's disease

Xin Liu et al.

Summary: This study discovered that the combination of polymannuronic acid (PM) and Lacticaseibacillus rhamnosus GG (LGG) provided neuroprotection in a chronic Parkinson's disease (PD) mice model. PM exerted neuroprotection through a short chain fatty acids (SCFAs)-mediated anti-inflammation and anti-apoptosis mechanism, while LGG may improve the expression of striatal glial cell-derived neurotrophic factor (GDNF) and increase the abundance of Clostridiales bacteria. The combination of PM and LGG showed better neuroprotective effects than using PM or LGG alone.

FOOD RESEARCH INTERNATIONAL (2022)

Add to Collection

Article Nutrition & Dietetics

Lactobacillus paracasei CCFM1229 and Lactobacillus rhamnosus CCFM1228 Alleviated Depression- and Anxiety-Related Symptoms of Chronic Stress-Induced Depression in Mice by Regulating Xanthine Oxidase Activity in the Brain

Mengshu Xu et al.

Summary: Supplementation with certain Lactobacillus strains has been found to have positive effects in reducing depressive and anxiety behaviors, increasing concentrations of serotonin and brain-derived neurotrophic factor in the brain, and regulating purine metabolism. These findings suggest a potential role of Lactobacillus in alleviating symptoms of depression and anxiety.

NUTRIENTS (2022)

Add to Collection

Article Neurosciences

Probiotics synergized with conventional regimen in managing Parkinson's disease

Hairong Sun et al.

Summary: The study found that co-administration of the probiotic Probio-M8 can improve sleep quality, alleviate anxiety, and gastrointestinal symptoms in patients with Parkinson's disease. It also has an impact on the host's gut microbiome, gut microbial metabolic potential, and serum metabolites.

NPJ PARKINSONS DISEASE (2022)

Add to Collection

Article Nutrition & Dietetics

Probiotic Bifidobacterium breve MCC1274 Mitigates Alzheimer's Disease-Related Pathologies in Wild-Type Mice

Mona Abdelhamid et al.

Summary: Probiotics, specifically Bifidobacterium breve MCC1274, have beneficial effects on brain function by improving memory and cognition through the microbiome-gut-brain axis. This study investigates the potential of B. breve MCC1274 to mitigate Alzheimer's disease-like pathologies in wild-type mice. The results show that oral administration of B. breve MCC1274 reduces A beta 42 levels, inhibits tau phosphorylation, decreases neuroinflammation, and improves synaptic protein levels in the hippocampus. These findings suggest that B. breve MCC1274 may have potential therapeutic effects for Alzheimer's disease.

NUTRIENTS (2022)

Add to Collection

Article Immunology

Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway

Jing Sun et al.

Summary: The study suggests that the probiotic Clostridium butyricum (Cb) has neuroprotective effects on Parkinson's disease (PD) by improving abnormal gut microbiota-gut-brain axis. This intervention could potentially reverse motor deficits, dopaminergic neuron loss, synaptic dysfunction, and microglia activation in PD, providing a new insight into treating PD through gut microbiota modulation.

BRAIN BEHAVIOR AND IMMUNITY (2021)

Add to Collection

Review Nutrition & Dietetics

Probiotics for dementia: a systematic review and meta-analysis of randomized controlled trials

Jenifer F. Kruger et al.

Summary: Probiotic supplementation did not show significant benefits on cognitive function in individuals with dementia, but did improve certain metabolic markers. The current evidence is insufficient to support the clinical application of probiotics and synbiotics for individuals with dementia.

NUTRITION REVIEWS (2021)

Add to Collection

Review Behavioral Sciences

The glutathione system in Parkinson's disease and its progression

Geir Bjorklund et al.

Summary: Redox dysfunctions and neuro-oxidative stress play a major role in the pathophysiology and progression of Parkinson's disease (PD). Lowered GSH metabolism and a low GSH/GSSG ratio following oxidative stress are associated with mitochondrial dysfunctions and neuroinflammatory processes accompanying PD. Antioxidant approaches may have therapeutic efficacy in treating PD and its progression by neutralizing reactive oxygen species.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)

Add to Collection

Review Immunology

Therapeutic role of inflammasome inhibitors in neurodegenerative disorders

Behnaz Lahooti et al.

Summary: Neuroinflammation characterized by glial cell activation is a hallmark of several neurological and neurodegenerative disorders, with chronic inflammation being a critical contributing factor for disease manifestation in conditions like HIV-1-associated neurocognitive disorders, Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Involvement of inflammasomes, particularly the NLRP complex, has been implicated in the development of these diseases, leading to the development of potential NLRP-targeting small-molecule therapeutics for the treatment of chronic neurological diseases.

BRAIN BEHAVIOR AND IMMUNITY (2021)

Add to Collection

Article Cell Biology

The Possible Role of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 on Locomotor Activity and Oxidative Stress in a Rotenone-Induced Zebrafish Model of Parkinson's Disease

Ovidiu-Dumitru Ilie et al.

Summary: The study showed that rotenone can induce Parkinson's disease-related symptoms in zebrafish, without statistically significant differences in social interaction and locomotor tests. However, significant changes were observed in locomotor activity, suggesting that rotenone may impair the movement ability of zebrafish.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Add to Collection

Article Cell Biology

Neuroprotective Effect of Ceftriaxone on MPTP-Induced Parkinson's Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota

Xiaoting Zhou et al.

Summary: Parkinson's disease is a common degenerative disease of the central nervous system that requires the development of new drugs for treatment. Ceftriaxone demonstrated a neuroprotective effect in a mouse model, reducing inflammation and improving gut microbiota.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Add to Collection

Article Neurosciences

Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation

Stefano Romano et al.

Summary: Recent studies have shown significant alterations in the gut microbiome of Parkinson's disease patients compared to healthy individuals, which may result in a pro-inflammatory status and impact the symptoms and pathophysiology of the disease.

NPJ PARKINSONS DISEASE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Oral Administration of Probiotic Bifidobacterium breve Improves Facilitation of Hippocampal Memory Extinction via Restoration of Aberrant Higher Induction of Neuropsin in an MPTP-Induced Mouse Model of Parkinson's Disease

Toshiaki Ishii et al.

Summary: The study showed that oral administration of Bifidobacterium breve strain A1 could reverse the facilitation of hippocampal memory extinction in PD mice, restoring abnormal changes in synaptic plasticity and facilitating fear extinction through regulating neuropsin expression levels.

BIOMEDICINES (2021)

Add to Collection

Review Clinical Neurology

The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options

Qing Wang et al.

Summary: Parkinson's disease patients show unique changes in gut microbiota, which may serve as early biomarkers of the disease. The alterations in gut microbiota composition may be related to the cause and symptoms of Parkinson's disease, but the specific mechanisms remain unclear. The microbiota-gut-brain axis provides a new pathway for understanding the pathophysiology of Parkinson's disease.

BRAIN (2021)

Add to Collection

Article Nutrition & Dietetics

Bifidobacterium Lactis Probio-M8 regulates gut microbiota to alleviate Alzheimer's disease in the APP/PS1 mouse model

Jianing Cao et al.

Summary: This study investigated the effects of probiotic Probio-M8 on Alzheimer's disease in a transgenic mouse model. The results showed that Probio-M8 reduced A beta plaque burden in the brain, protected against gut microbiota dysbiosis, and alleviated cognitive impairment in the mice.

EUROPEAN JOURNAL OF NUTRITION (2021)

Add to Collection

Article Microbiology

Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis

Zhe Zhao et al.

Summary: This study demonstrates that FMT treatment can correct gut microbiota dysbiosis and ameliorate the rotenone-induced PD mouse model, possibly playing a significant role in suppressing inflammation via the LPS-TLR4 signaling pathway in both the gut and the brain. Furthermore, the study proves the involvement of rotenone-induced microbiota dysbiosis in the genesis of PD through the microbiota-gut-brain axis.

MICROBIOME (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson's Disease: Roads to Biomarker Discovery

Anna Picca et al.

Summary: Parkinson's Disease is a common neurodegenerative disease among older adults, characterized by dopaminergic neuron loss and abnormal accumulation of alpha-synuclein. The development of PD involves various factors such as genetic mutations, post-translational modifications, and mitochondrial dysfunction. The overproduction of reactive oxygen species activates alpha-synuclein aggregation, leading to neurodegeneration.

BIOMOLECULES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

1,5-Benzodiazepin-2(3H)-ones: In Vitro Evaluation as Antiparkinsonian Agents

Ana Ortiz de Zarate et al.

Summary: A series of new 1,5-benzodiazepin-2-ones were synthesized and evaluated for their antioxidant and neuroprotectant properties. Some compounds showed promising activity in protecting neurons from oxidative stress, suggesting their potential for the development of new therapeutic agents against Parkinson's disease.

ANTIOXIDANTS (2021)

Add to Collection

Article Nutrition & Dietetics

Administration of Bifidobacterium breve Improves the Brain Function of Aβ1-42-Treated Mice via the Modulation of the Gut Microbiome

Guangsu Zhu et al.

Summary: This study found that the administration of bifidobacteria improved behavioral abnormalities and synaptic plasticity in an AD mouse model. The microbiome and metabolomic profiles of the mice indicated a correlation between specific bacterial taxa and their metabolites with AD-associated behaviors, suggesting the involvement of the gut-brain axis in the pathophysiology of AD. Overall, B. breve CCFM1025 and WX represent a novel probiotic dietary intervention for delaying the progression of AD by modulating the gut microbiome.

NUTRIENTS (2021)

Add to Collection

Review Cell Biology

Western diet as a trigger of Alzheimer's disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration

Angelika Wieckowska-Gacek et al.

Summary: The studies suggest that an excess of saturated fatty acids and simple sugars in the diet is a known environmental risk factor of Alzheimer's disease. The systemic alterations induced by a Western diet, including metabolic changes, obesity, inflammation, may drive impairment of the blood-brain barrier and neuroinflammation, leading to neurodegeneration and cognitive impairment.

AGEING RESEARCH REVIEWS (2021)

Add to Collection

Review Neurosciences

Parkinson's Disease Genetics and Pathophysiology

Gabriel E. Vazquez-Velez et al.

Summary: Parkinson's disease is a common neurodegenerative disorder characterized by degeneration of the substantia nigra pars compacta and accumulation of alpha-synuclein in Lewy bodies. Genetic factors play an important role in PD pathophysiology, with dysfunction of endosomal, lysosomal, and mitochondrial pathways being associated with the disease. This knowledge could be utilized for developing disease-modifying therapeutics.

ANNUAL REVIEW OF NEUROSCIENCE, VOL 44, 2021 (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Antioxidant activity of calycosin against α-synuclein amyloid fibrils-induced oxidative stress in neural-like cells as a model of preventive care studies in Parkinson's disease

Qichen Pan et al.

Summary: The study demonstrated that calycosin significantly inhibits the fibril formation of α-syn in a concentration-dependent manner, preventing α-syn amyloid-triggered neurotoxicity. By modifying the aggregation pathway, calycosin promotes the formation of non-toxic species, restoring SOD/CAT activity and GSH content while reducing ROS levels and caspase-3 activity. This research provides valuable insights into the mechanism of α-syn amyloid inhibition by calycosin and suggests the development of small molecules-based therapeutic platforms for Parkinson's disease.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)

Add to Collection

Review Oncology

Roles of α-synuclein in gastrointestinal microbiome dysbiosis-related Parkinson's disease progression

Qingchun Lei et al.

Summary: Parkinson's disease is the second most common neurodegenerative disease among middle-aged and elderly populations. The microbiota-gut-brain axis plays a key role in the pathogenesis of PD by causing abnormal aggregation and transport of alpha-synuclein, leading to inflammation and oxidative stress, resulting in neuronal loss and disease progression. Therapeutic strategies aimed at improving the gut microbiome and reducing alpha-synuclein accumulation are discussed in relation to relieving symptoms and slowing the progression of PD.

MOLECULAR MEDICINE REPORTS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Schisandra chinensis protects against dopaminergic neuronal oxidative stress, neuroinflammation and apoptosis via the BDNF/Nrf2/NF-κB pathway in 6-OHDA-induced Parkinson's disease mice

Tingxu Yan et al.

Summary: The study revealed that Schisandra chinensis protects against dopaminergic neurodegeneration in 6-OHDA-induced Parkinson's disease mice by modulating the BDNF/Nrf2/NF-kappa B signaling pathway to suppress oxidative stress, neuroinflammation, and apoptosis.

FOOD & FUNCTION (2021)

Add to Collection

Review Clinical Neurology

Parkinson's disease and the gastrointestinal microbiome

Michal Lubomski et al.

JOURNAL OF NEUROLOGY (2020)

Add to Collection

Article Cell Biology

Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice

Jinbo Cheng et al.

AUTOPHAGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

BDNF as a Promising Therapeutic Agent in Parkinson's Disease

Ewelina Palasz et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Neurosciences

Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease

Hemraj B. Dodiya et al.

NEUROBIOLOGY OF DISEASE (2020)

Add to Collection

Article Neurosciences

Anti-neuroinflammatory, protective effects of the synthetic microneurotrophin BNN-20 in the advanced dopaminergic neurodegeneration of weaver mice

Vasiliki Panagiotakopoulou et al.

NEUROPHARMACOLOGY (2020)

Add to Collection

Article Neurosciences

Twice subacute MPTP administrations induced time-dependent dopaminergic neurodegeneration and inflammation in midbrain and ileum, as well as gut microbiota disorders in PD mice

Wenjun Xie et al.

NEUROTOXICOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection

Yao Wei et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease and Dopa-Responsive Dystonia

Ichiro Kawahata et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Neurosciences

Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson's Disease

Tsung-Hsun Hsieh et al.

BRAIN SCIENCES (2020)

Add to Collection

Article Immunology

Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson's disease

Jian-Fu Liao et al.

BRAIN BEHAVIOR AND IMMUNITY (2020)

Add to Collection

Article Neurosciences

Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells

Tyler J. Wenzel et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2020)

Add to Collection

Review Pharmacology & Pharmacy

Targeting the microbiota in pharmacology of psychiatric disorders

Alessia Pascale et al.

PHARMACOLOGICAL RESEARCH (2020)

Add to Collection

Review Neurosciences

Glycosphingolipids and neuroinflammation in Parkinson's disease

Karim Belarbi et al.

MOLECULAR NEURODEGENERATION (2020)

Add to Collection

Article Neurosciences

Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson's Disease

Tian-Jiao Chen et al.

FRONTIERS IN NEUROSCIENCE (2020)

Add to Collection

Article Nutrition & Dietetics

Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial

Omid Reza Tamtaji et al.

CLINICAL NUTRITION (2019)

Add to Collection

Article Cell Biology

Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease

Xiaojuan Han et al.

AUTOPHAGY (2019)

Add to Collection

Article Immunology

Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort

Ping Liu et al.

BRAIN BEHAVIOR AND IMMUNITY (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

Assessment of the Levels of Level of Biomarkers of Bone Matrix Glycoproteins and Inflammatory Cytokines from Saudi Parkinson Patients

Aziza Alrafiah et al.

BIOMED RESEARCH INTERNATIONAL (2019)

Add to Collection

Review Biotechnology & Applied Microbiology

Akkermansia muciniphila is a promising probiotic

Ting Zhang et al.

MICROBIAL BIOTECHNOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

Intestinal infection triggers Parkinson's disease-like symptoms in Pink1-/- mice

Diana Matheoud et al.

NATURE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Bifidobacterium with the role of 5-hydroxytryptophan synthesis regulation alleviates the symptom of depression and related microbiota dysbiosis

Peijun Tian et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2019)

Add to Collection

Article Multidisciplinary Sciences

Dual microglia effects on blood brain barrier permeability induced by systemic inflammation

Koichiro Haruwaka et al.

NATURE COMMUNICATIONS (2019)

Add to Collection

Review Medicine, General & Internal

Parkinson's Disease and Parkinsonism

Michael T. Hayes

AMERICAN JOURNAL OF MEDICINE (2019)

Add to Collection

Article Gastroenterology & Hepatology

Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice

Arno Hanninen et al.

GUT (2018)

Add to Collection

Article Agriculture, Multidisciplinary

Short-Chain Fatty Acids Suppress Inflammatory Reactions in Caco-2 Cells and Mouse Colons

Tran Van Hung et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)

Add to Collection

Article Immunology

Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLRLI/TNF-α signaling pathway

Meng-Fei Sun et al.

BRAIN BEHAVIOR AND IMMUNITY (2018)

Add to Collection

Article Immunology

Alteration of the fecal microbiota in Chinese patients with Parkinson's disease

Yiwei Qian et al.

BRAIN BEHAVIOR AND IMMUNITY (2018)

Add to Collection

Article Neurosciences

Parkinson's disease from the gut

Rodger A. Liddle

BRAIN RESEARCH (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease

Valentina Caputi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Add to Collection

Review Immunology

Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis

Xi Chen et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Mechanisms regulating intestinal barrier integrity and its pathological implications

Chaithanya Chelakkot et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2018)

Add to Collection

Article Biochemistry & Molecular Biology

A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice

Hubert Plovier et al.

NATURE MEDICINE (2017)

Add to Collection

Article Neurosciences

Functional alterations of the dopaminergic and glutamatergic systems in spontaneous α-synuclein overexpressing rats

Ezia Guatteo et al.

EXPERIMENTAL NEUROLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease

Yodai Kobayashi et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Article Neurosciences

Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice

Aurelijus Burokas et al.

BIOLOGICAL PSYCHIATRY (2017)

Add to Collection

Review Immunology

The blood-brain barrier in systemic inflammation

Aravinthan Varatharaj et al.

BRAIN BEHAVIOR AND IMMUNITY (2017)

Add to Collection

Review Neurosciences

The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis?

Madelyn C. Houser et al.

NPJ PARKINSONS DISEASE (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease

Timothy R. Sampson et al.

CELL (2016)

Add to Collection

Article Clinical Neurology

Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT

Michela Barichella et al.

NEUROLOGY (2016)

Add to Collection

Article Clinical Neurology

Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls

Marcus M. Unger et al.

PARKINSONISM & RELATED DISORDERS (2016)

Add to Collection

Review Pharmacology & Pharmacy

Targeting Oxidative Stress in Central Nervous System Disorders

Manisha Patel

TRENDS IN PHARMACOLOGICAL SCIENCES (2016)

Add to Collection

Article Geriatrics & Gerontology

Nonmotor gastrointestinal disorders in older patients with Parkinson's disease: is there hope?

Doina Georgescu et al.

CLINICAL INTERVENTIONS IN AGING (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells

Christopher S. Reigstad et al.

FASEB JOURNAL (2015)

Add to Collection

Review Clinical Neurology

Gastrointestinal dysfunction in Parkinson's disease

Alfonso Fasano et al.

LANCET NEUROLOGY (2015)

Add to Collection

Article Endocrinology & Metabolism

Biomarkers of Parkinson's disease: Present and future

Diane B. Miller et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2015)

Add to Collection

Article Clinical Neurology

Gut Microbiota Are Related to Parkinson's Disease and Clinical Phenotype

Filip Scheperjans et al.

MOVEMENT DISORDERS (2015)

Add to Collection

Review Biochemistry & Molecular Biology

Glutathione metabolism and Parkinson's disease

Michelle Smeyne et al.

FREE RADICAL BIOLOGY AND MEDICINE (2013)

Add to Collection

Review Biochemistry & Molecular Biology

Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease

Michael H. Yan et al.

FREE RADICAL BIOLOGY AND MEDICINE (2013)

Add to Collection

Review Neurosciences

The Central Theme of Parkinson's Disease: α-Synuclein

Mehmet Ozansoy et al.

MOLECULAR NEUROBIOLOGY (2013)

Add to Collection

Review Pharmacology & Pharmacy

GDNF, NGF and BDNF as therapeutic options for neurodegeneration

Shelley J. Allen et al.

PHARMACOLOGY & THERAPEUTICS (2013)

Add to Collection

Article Clinical Neurology

5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease - opportunities for novel therapeutics to reduce the problems of levodopa therapy

SL Nicholson et al.

EUROPEAN JOURNAL OF NEUROLOGY (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.